Biblio

Luo L, Zhang L, Cai B, Li H, Huang W, Jing Y, Zhu H, Zhao Y, Bo J, Wang Q, et al. Post-transplant lymphoproliferative disease after allogeneic hematopoietic stem cell transplantation: A single-center experience. Ann Transplant. 2014;19:6-12.

• PubMed
• Google Scholar

Huang J, Guo X, Fan N, Song J, Zhao B, Ouyang Z, Liu Z, Zhao Y, Yan Q, Yi X, et al. RAG1/2 Knockout Pigs with Severe Combined Immunodeficiency. J Immunol. 2014.

• PubMed
• Google Scholar

Liao M, Cui Q, Hu Y, Xing J, Wu D, Zheng S, Zhao Y, Yu Y, Sun J, Chai R. Recent advances in the application of MXenes for neural tissue engineering and regeneration. Neural Regen Res. 2024;19(2):258-263.

• PubMed
• Google Scholar

Tang H, Zhang P, Zeng L, Zhao Y, Xie L, Chen B. Retraction Note: Mesenchymal stem cells ameliorate renal fibrosis by galectin-3/Akt/GSK3β/Snail signaling pathway in adenine-induced nephropathy rat. Stem Cell Res Ther. 2024;15(1):52.

• PubMed
• Google Scholar

Liu M, Li Y, Zhang Y, Zhao X, Zhai B, Zhang Q, Wang L, Zhao Y, Li H, Wang Q, et al. Secondary Antifungal Prophylaxis in Hematological Malignancy Patients with Previous Invasive Fungal Disease: A Retrospective Analysis. PLoS One. 2014;9(12):e115461.

• PubMed
• Google Scholar

Li N, Zhang M, Drummen GPC, Zhao Y, Tan YFen, Luo S, Qu XBo. Sika Deer Antler Collagen Type I-Accelerated Osteogenesis in Bone Marrow Mesenchymal Stem Cells via the Smad Pathway. Evid Based Complement Alternat Med. 2016;2016:2109204.

• PubMed
• Google Scholar

Oprescu SN, Baumann N, Chen X, Sun Q, Zhao Y, Yue F, Wang H, Kuang S. Sox11 is enriched in myogenic progenitors but dispensable for development and regeneration of the skeletal muscle. Skelet Muscle. 2023;13(1):15.

• PubMed
• Google Scholar

Jing Y, Chen H, Liu M, Zhou M, Guo Y, Gao C, Wang Q, Li H, Zhao Y, Bo J, et al. Susceptibility Of Ph-Positive All To Tki Therapy Associated With Bcr-Abl Rearrangement Patterns: A Retrospective Analysis. PLoS One. 2014;9(11):e110431.

• PubMed
• Google Scholar

Li H, Jin Y, Zhao Y, Li W, He Z, Zhang Q, Huang H, Lin J, Chen Y, Xing D, et al. Targeted cell therapy for partial-thickness cartilage defects using membrane modified mesenchymal stem cells by transglutaminase 2. Biomaterials. 2021;275:120994.

• PubMed
• Google Scholar

Liu W, Zhao Y, Liu Z, Zhang G, Wu H, Zheng X, Tang X, Chen ZG. Therapeutic effects against high-grade glioblastoma mediated by engineered induced neural stem cells combined with GD2-specific CAR-NK. Cell Oncol (Dordr). 2023.

• PubMed
• Google Scholar

Zhao Y, Liu Z, Wang X, Wu H, Zhang J, Yang J, Zhang F, Liu L, Long J, Lu P, et al. Treatment with humanized selective CD19CAR-T cells shows efficacy in highly treated B-ALL patients who have relapsed after receiving murine-based CD19CAR-T therapies. Clin Cancer Res. 2019.

• PubMed
• Google Scholar